US7078042B2
(en)
*
|
1995-09-15 |
2006-07-18 |
Uab Research Foundation |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
JP2000506385A
(ja)
*
|
1996-02-20 |
2000-05-30 |
スミスクライン・ビーチャム・コーポレイション |
新規era
|
GB9607991D0
(en)
*
|
1996-04-18 |
1996-06-19 |
Smithkline Beecham Plc |
Novel compounds
|
US5795758A
(en)
*
|
1997-04-18 |
1998-08-18 |
Smithkline Beecham Corporation |
DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
|
GB9608000D0
(en)
*
|
1996-04-18 |
1996-06-19 |
Smithkline Beecham Plc |
Novel compounds
|
US6270999B1
(en)
|
1997-04-10 |
2001-08-07 |
Smithkline Beecham Corporation |
Compounds
|
US5834276A
(en)
*
|
1996-04-18 |
1998-11-10 |
Smithkline Beecham Corporation |
Asparaginyl TRNA synthetase polynucleotides of streptococcus
|
GB9607993D0
(en)
|
1996-04-18 |
1996-06-19 |
Smithkline Beecham Plc |
Novel compounds
|
US5968777A
(en)
*
|
1996-04-18 |
1999-10-19 |
Smithkline Beecham Corporation |
DNA encoding seryl t-RNA synthetase
|
JP2000509984A
(ja)
*
|
1996-05-01 |
2000-08-08 |
スミスクライン・ビーチャム・コーポレイション |
新規化合物
|
US6165989A
(en)
*
|
1996-05-14 |
2000-12-26 |
Smithkline Beecham Corporation |
Era of Streptococcus pneumoniae
|
WO1997043303A1
(en)
*
|
1996-05-14 |
1997-11-20 |
Smithkline Beecham Corporation |
Novel compounds
|
US5712108A
(en)
*
|
1996-05-29 |
1998-01-27 |
Eli Lilly And Company |
Peptidoglycan biosynthetic mure protein from streptocuccus pneumoniae
|
US5681694A
(en)
*
|
1996-06-18 |
1997-10-28 |
Eli Lilly And Company |
Murd protein method and kit for identification of inhibitors
|
EP0816502A3
(en)
*
|
1996-07-03 |
1999-10-20 |
Smithkline Beecham Corporation |
Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae
|
GB9613907D0
(en)
|
1996-07-03 |
1996-09-04 |
Smithkline Beecham Plc |
Novel compounds
|
US5776733A
(en)
*
|
1996-07-25 |
1998-07-07 |
Eli Lilly And Company |
Biosynthetic gene DD1 from Streptococcus pneumoniae
|
US5691161A
(en)
*
|
1996-08-01 |
1997-11-25 |
Eli Lilly And Company |
Peptidoglycan biosynthetic mura protein from Streptococcus pneumoniae
|
US6284878B1
(en)
|
1996-08-16 |
2001-09-04 |
Smithkline Beecham Corporation |
def1
|
US6165762A
(en)
*
|
1996-08-16 |
2000-12-26 |
Smithkline Beecham Corporation |
DNA encoding adenine phosphoribosyltransferase from Streptococcus pneumoniae
|
WO1998006734A1
(en)
*
|
1996-08-16 |
1998-02-19 |
Smithkline Beecham Corporation |
Novel prokaryotic polynucleotides, polypeptides and their uses
|
US5858718A
(en)
*
|
1997-07-08 |
1999-01-12 |
Smithkline Beecham Corporation |
Pcr a
|
GB9619071D0
(en)
*
|
1996-09-12 |
1996-10-23 |
Smithkline Beecham Plc |
Novel compounds
|
US5882871A
(en)
*
|
1996-09-24 |
1999-03-16 |
Smithkline Beecham Corporation |
Saliva binding protein
|
US5928895A
(en)
*
|
1996-09-24 |
1999-07-27 |
Smithkline Beecham Corporation |
IgA Fc binding protein
|
US5882896A
(en)
*
|
1996-09-24 |
1999-03-16 |
Smithkline Beecham Corporation |
M protein
|
US6225083B1
(en)
*
|
1996-10-01 |
2001-05-01 |
Smithkline Beecham Corporation |
FtsL from Streptococcus pneumoniae
|
US5910414A
(en)
*
|
1996-10-15 |
1999-06-08 |
Smithkline Beecham Corporation |
Topoisomerase I of streptococcus pneumoniae
|
US5789202A
(en)
*
|
1996-10-17 |
1998-08-04 |
Eli Lilly And Company |
DNA encoding a novel penicillin binding protein from streptococcus pneumoniae
|
US6096518A
(en)
|
1996-10-24 |
2000-08-01 |
Smithkline Beecham Corporation |
DNA encoding SPO/REL polypeptides of streptococcus
|
US6022710A
(en)
*
|
1996-10-25 |
2000-02-08 |
Smithkline Beecham Corporation |
Nucleic acid encoding greA from Streptococcus pneumoniae
|
AU5194598A
(en)
*
|
1996-10-31 |
1998-05-22 |
Human Genome Sciences, Inc. |
(streptococcus pneumoniae) antigens and vaccines
|
US6887663B1
(en)
*
|
1996-10-31 |
2005-05-03 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae SP036 polynucleotides
|
US5821335A
(en)
*
|
1996-11-19 |
1998-10-13 |
Eli Lilly And Company |
Biosynthetic gene murg from streptococcus pneumoniae
|
US5786197A
(en)
*
|
1996-11-25 |
1998-07-28 |
Smithkline Beecham Corporation |
lep
|
US6287803B1
(en)
*
|
1996-11-27 |
2001-09-11 |
Smithkline Beecham Corporation |
Polynucleotides encoding a novel era polypeptide
|
US5948645A
(en)
*
|
1996-12-04 |
1999-09-07 |
Eli Lilly And Company |
Biosynthetic gene muri from Streptococcus pneumoniae
|
EP0854188A3
(en)
*
|
1997-01-21 |
2000-02-09 |
Smithkline Beecham |
Streptococcus pneumoniae aroE polypeptides and polynucleotides
|
EP0863205A1
(en)
*
|
1997-02-10 |
1998-09-09 |
Smithkline Beecham Corporation |
Def2 protein from Streptococcus pneumoniae
|
EP0863152A3
(en)
*
|
1997-02-10 |
2000-04-19 |
Smithkline Beecham Corporation |
Streptococcus pneumoniae Def1 protein
|
US6228838B1
(en)
*
|
1997-02-28 |
2001-05-08 |
Smithkline Beecham Corporation |
LicD1 polypeptides
|
US6110899A
(en)
|
1997-02-28 |
2000-08-29 |
Smithkline Beecham Corporation |
LICC of Streptococcus pneumoniae
|
US5962295A
(en)
*
|
1997-02-28 |
1999-10-05 |
Smithkline Beecham Corporation |
LicB polypeptides from Streptococcus pneumoniae
|
CA2230497A1
(en)
*
|
1997-02-28 |
1998-08-28 |
Smithkline Beecham Corporation |
Novel lica
|
DE19708537A1
(de)
*
|
1997-03-03 |
1998-09-10 |
Biotechnolog Forschung Gmbh |
Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
|
US6074858A
(en)
*
|
1997-04-18 |
2000-06-13 |
Smithkline Beecham Corporation |
Cysteinyl TRNA synthetase from Streptococcus pneumoniae
|
US6210940B1
(en)
|
1997-04-18 |
2001-04-03 |
Smithkline Beecham Corporation |
Compounds
|
US6676943B1
(en)
|
1997-04-24 |
2004-01-13 |
Regents Of The University Of Minnesota |
Human complement C3-degrading protein from Streptococcus pneumoniae
|
AU740153B2
(en)
*
|
1997-04-24 |
2001-11-01 |
Regents Of The University Of Minnesota |
Human complement C3-degrading proteinase from streptococcus pneumoniae
|
US5919664A
(en)
*
|
1997-05-29 |
1999-07-06 |
Smithkline Beecham Corporation |
Peptide release factor, prfC (RF-3), a GTP-Binding protein
|
US6165991A
(en)
*
|
1997-05-30 |
2000-12-26 |
Smithkline Beecham Corporation |
Sensor histidine kinase of Streptococcus pneumoniae
|
US6165992A
(en)
*
|
1997-05-30 |
2000-12-26 |
Smithkline Beecham Corporation |
Histidine kinase
|
US6287836B1
(en)
*
|
1997-05-30 |
2001-09-11 |
Smithkline Beecham Corporation |
Histidine kinase from Streptococcus pneumoniae and compositions therecontaining
|
EP0881297A3
(en)
*
|
1997-05-30 |
2002-05-08 |
Smithkline Beecham Corporation |
Histidine kinase
|
US5866365A
(en)
*
|
1997-06-05 |
1999-02-02 |
Smithkline Beecham Corporation |
RNC polynucleotides
|
US5882889A
(en)
*
|
1997-06-13 |
1999-03-16 |
Smithkline Beecham Corporation |
Response regulator in a two component signal transduction system
|
EP0885963A3
(en)
*
|
1997-06-20 |
1999-12-29 |
Smithkline Beecham Corporation |
Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide
|
EP0885965A3
(en)
*
|
1997-06-20 |
2000-01-12 |
Smithkline Beecham Corporation |
Histidine kinase polypeptides
|
EP0891984A3
(en)
|
1997-06-20 |
2000-01-19 |
Smithkline Beecham Corporation |
Nucleic acid encoding streptococcus pneumoniae response regulator
|
EP0885966A3
(en)
*
|
1997-06-20 |
1999-12-29 |
Smithkline Beecham Corporation |
Novel compouds
|
US6140061A
(en)
*
|
1997-06-20 |
2000-10-31 |
Smithkline Beecham Corporation |
Response regulator
|
US6268172B1
(en)
*
|
1997-06-20 |
2001-07-31 |
Smithkline Beecham Corporation |
Compounds
|
EP0885903A3
(en)
*
|
1997-06-20 |
2000-01-19 |
Smithkline Beecham Corporation |
Nucleic acid encoding streptococcus pheumoniae response regulator
|
US6270991B1
(en)
|
1997-06-20 |
2001-08-07 |
Smithkline Beecham Corporation |
Histidine kinase
|
CA2236441A1
(en)
*
|
1997-07-01 |
1999-01-01 |
Smithkline Beecham Corporation |
Gida2
|
US5866366A
(en)
*
|
1997-07-01 |
1999-02-02 |
Smithkline Beecham Corporation |
gidB
|
US6238882B1
(en)
*
|
1997-07-01 |
2001-05-29 |
Smithkline Beecham Corporation |
GidA1
|
US6800744B1
(en)
*
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
US7129340B1
(en)
|
1997-07-02 |
2006-10-31 |
sanofi pasteur limited/sanofi pasteur limitée |
Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
|
EP0890641A1
(en)
*
|
1997-07-10 |
1999-01-13 |
Smithkline Beecham Corporation |
Novel IspA
|
EP0915159A1
(en)
*
|
1997-07-17 |
1999-05-12 |
Smithkline Beecham Corporation |
Novel xanthine phosphoribosyl transferase
|
US5994101A
(en)
*
|
1997-07-18 |
1999-11-30 |
Smithkline Beecham Corporation |
DNA encoding gidA1 polypeptides
|
CA2237043A1
(en)
*
|
1997-07-18 |
1999-01-18 |
Smithkline Beecham Corporation |
Response regulator
|
EP0894857A3
(en)
*
|
1997-08-01 |
2001-09-26 |
Smithkline Beecham Corporation |
SecA gene from Streptococcus pneumoniae
|
US5840538A
(en)
*
|
1997-08-06 |
1998-11-24 |
Smithkline Beecham Corporation |
Lgt
|
EP0896061A3
(en)
*
|
1997-08-08 |
2000-07-26 |
Smithkline Beecham Corporation |
RpoA gene from Staphylococcus aureus
|
US5929045A
(en)
*
|
1997-08-12 |
1999-07-27 |
Smithkline Beecham Corporation |
Recombinant expression of polynucleotides encoding the UDP-N-acetylmuramoylalanine:D-glutamate ligase (MurD) of Streptococcus pneumoniae
|
US6197300B1
(en)
*
|
1997-08-12 |
2001-03-06 |
Smithkline Beecham Corporation |
ftsZ
|
US5888770A
(en)
*
|
1997-08-26 |
1999-03-30 |
Smithkline Beecham Corporation |
Spoiiie
|
US6072032A
(en)
*
|
1997-08-29 |
2000-06-06 |
Smithkline Beecham Corporation |
FtsY polypeptides from Streptococcus pneumoniae
|
US5882898A
(en)
*
|
1997-08-29 |
1999-03-16 |
Smithkline Beecham Corporation |
Streptococcus pneumoniae polynucleotides which encode folyl-polyglutamate synthetase (FPGS) polypeptides
|
US6225087B1
(en)
*
|
1997-09-09 |
2001-05-01 |
Smithkline Beecham Corporation |
Response regulator
|
EP0902087A3
(en)
*
|
1997-09-10 |
2000-03-15 |
SmithKline Beecham Corporation |
Histidine kinase
|
EP0913478A3
(en)
*
|
1997-09-17 |
1999-12-29 |
Smithkline Beecham Corporation |
Histidine kinase from Streptococcus pneumoniae 0100993
|
US5866369A
(en)
*
|
1997-09-18 |
1999-02-02 |
Smithkline Beecham Corporation |
Amps
|
US5885804A
(en)
*
|
1997-09-18 |
1999-03-23 |
Smithkline Beecham Corporation |
PhoH
|
CN1291233A
(zh)
*
|
1997-09-24 |
2001-04-11 |
美国明尼苏达州大学 |
来自肺炎链球菌之人类补体c3降解蛋白酶
|
EP0905249A3
(en)
*
|
1997-09-25 |
1999-08-04 |
Smithkline Beecham Corporation |
Alcohol dehydrogenase
|
US6194170B1
(en)
|
1997-09-25 |
2001-02-27 |
Smithkline Beecham Corporation |
MurF of Streptococcus pneumoniae
|
CA2244954A1
(en)
*
|
1997-09-25 |
1999-03-25 |
Smithkline Beecham Corporation |
Murf
|
US6121028A
(en)
*
|
1997-10-10 |
2000-09-19 |
Smithkline Beecham Corporation |
MurE
|
US6331411B1
(en)
*
|
1997-10-14 |
2001-12-18 |
Smithkline Beecham Corporation |
TopA
|
EP0913479A3
(en)
*
|
1997-10-27 |
2000-10-25 |
Smithkline Beecham Corporation |
Adenine glycosylase
|
US5861281A
(en)
*
|
1997-10-30 |
1999-01-19 |
Smithkline Beecham Corporation |
Lacc
|
US6165763A
(en)
*
|
1997-10-30 |
2000-12-26 |
Smithkline Beecham Corporation |
Ornithine carbamoyltransferase
|
EP0913480A3
(en)
*
|
1997-11-03 |
2001-07-11 |
Smithkline Beecham Corporation |
Chorismate synthase
|
EP0964921A4
(en)
*
|
1997-11-05 |
2002-01-23 |
Smithkline Beecham Corp |
NEW ERS FROM STREPTOCOCCUS
|
US20020058799A1
(en)
*
|
1998-05-18 |
2002-05-16 |
Sanjoy Biswas |
Novel pth
|
AU1866099A
(en)
*
|
1997-12-31 |
1999-07-26 |
Stressgen Biotechnologies Corporation |
Streptococcal heat shock proteins of the hsp60 family
|
KR20010033721A
(ko)
|
1997-12-31 |
2001-04-25 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
필수 세균 유전자 및 이의 용도
|
CN1944652A
(zh)
|
1998-02-20 |
2007-04-11 |
益德生物医药公司 |
B组链球菌抗原
|
BR9909483A
(pt)
*
|
1998-04-07 |
2001-10-09 |
Medimmune Inc |
Derivados de proteìnas ligantes pneumococcal colina para vacinas
|
US6858706B2
(en)
*
|
1998-04-07 |
2005-02-22 |
St. Jude Children's Research Hospital |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
|
CA2326388C
(en)
*
|
1998-04-07 |
2014-02-04 |
St. Jude Children's Research Hospital |
A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
|
GB9808350D0
(en)
*
|
1998-04-22 |
1998-06-17 |
Glaxo Group Ltd |
Bacterial polypeptide family
|
GB9808363D0
(en)
*
|
1998-04-22 |
1998-06-17 |
Glaxo Group Ltd |
Bacterial polypeptide family
|
US20010016200A1
(en)
*
|
1998-04-23 |
2001-08-23 |
Briles David E. |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
JP2002515240A
(ja)
*
|
1998-05-18 |
2002-05-28 |
スミスクライン・ビーチャム・コーポレイション |
ストレプトコッカス・ニュモニエのclpX
|
JP2002516078A
(ja)
*
|
1998-05-28 |
2002-06-04 |
スミスクライン・ビーチャム・コーポレイション |
acpS
|
US6660520B2
(en)
|
1998-06-05 |
2003-12-09 |
Smithkline Beecham Corporation |
Nrde
|
US6190881B1
(en)
*
|
1998-06-05 |
2001-02-20 |
Smithkline Beecham Corporation |
Ribonucleotide diphosphate reductase, nrdF, of streptococcus pneumoniae
|
AU4337099A
(en)
*
|
1998-06-11 |
1999-12-30 |
St. Jude Children's Research Hospital |
Zmpb, a new determinant of virulence for (streptococcus pneumoniae), vaccine derived therefrom and uses thereof
|
JP2002519055A
(ja)
*
|
1998-07-02 |
2002-07-02 |
スミスクライン・ビーチャム・コーポレイション |
Ftsz多量体蛋白およびその使用
|
EP1100879A1
(en)
*
|
1998-07-24 |
2001-05-23 |
SmithKline Beecham Corporation |
Pneumococcal nrdg protein
|
US20030134407A1
(en)
|
1998-07-27 |
2003-07-17 |
Le Page Richard William Falla |
Nucleic acids and proteins from Streptococcus pneumoniae
|
EP1100920A2
(en)
*
|
1998-07-27 |
2001-05-23 |
Microbial Technics Limited |
Nucleic acids and proteins from group b streptococcus
|
EP1790730A3
(en)
*
|
1998-07-27 |
2007-09-12 |
Sanofi Pasteur Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
EP2053126A1
(en)
*
|
1998-07-27 |
2009-04-29 |
Sanofi Pasteur Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
US6936252B2
(en)
|
1998-07-27 |
2005-08-30 |
Microbial Technics Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
US7098182B2
(en)
|
1998-07-27 |
2006-08-29 |
Microbial Technics Limited |
Nucleic acids and proteins from group B streptococcus
|
EP1801218A3
(en)
*
|
1998-07-27 |
2007-10-10 |
Sanofi Pasteur Limited |
Nucleic acids and proteins from streptococcus pneumoniae
|
EP1624064A3
(en)
*
|
1998-07-27 |
2006-05-10 |
Microbial Technics Limited |
Nucleic acids and proteins from streptococcus pneumoniae
|
EP1144640A3
(en)
*
|
1998-07-27 |
2001-11-28 |
Microbial Technics Limited |
Nucleic acids and proteins from streptococcus pneumoniae
|
EP1030685A4
(en)
*
|
1998-09-09 |
2001-04-25 |
Millennium Pharm Inc |
ESSENTIAL BACTERIAL GENES AND THEIR USE
|
US6268177B1
(en)
|
1998-09-22 |
2001-07-31 |
Smithkline Beecham Corporation |
Isolated nucleic acid encoding nucleotide pyrophosphorylase
|
US6225457B1
(en)
|
1998-09-23 |
2001-05-01 |
Smithkline Beecham Corporation |
murF2
|
BR9914066A
(pt)
*
|
1998-09-24 |
2002-04-23 |
Univ Minnesota |
Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae
|
JP2002525101A
(ja)
*
|
1998-09-28 |
2002-08-13 |
スミスクライン・ビーチャム・コーポレイション |
Map
|
US20030082614A1
(en)
*
|
2001-05-29 |
2003-05-01 |
Sanjoy Biswas |
Map
|
US6515119B1
(en)
*
|
1998-09-30 |
2003-02-04 |
Millennium Pharmaceuticals, Inc. |
Use of S-ydcB and B-ydcB, essential bacterial genes
|
US6537774B1
(en)
*
|
1998-10-14 |
2003-03-25 |
Smithkline Beecham Corporation |
UPS (undecaprenyl diphosphate synthase
|
US6255075B1
(en)
*
|
1998-10-20 |
2001-07-03 |
Smithkline Beecham Corporation |
Bira
|
US6110685A
(en)
*
|
1998-10-28 |
2000-08-29 |
Smithkline Beecham Corporation |
infB
|
US6228625B1
(en)
*
|
1998-11-03 |
2001-05-08 |
Smithkline Beecham Corporation |
metK from Streptococcus pneumoniae
|
WO2000026359A1
(en)
*
|
1998-11-04 |
2000-05-11 |
Smithkline Beecham Corporation |
ftsX
|
US6165764A
(en)
*
|
1998-11-09 |
2000-12-26 |
Smithkline Beecham Corporation |
Polynucleotides encoding tRNA methyl transferases from Streptococcus pneumoniae
|
US6495139B2
(en)
*
|
1998-11-19 |
2002-12-17 |
St. Jude Children's Research Hospital |
Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
|
AU2027400A
(en)
*
|
1998-11-19 |
2000-06-05 |
St. Jude Children's Research Hospital |
Identification and characterization of novel pneumococcal choline binding proteins, cbpg and cbpd, and diagnostic and therapeutic uses thereof
|
US6277595B1
(en)
*
|
1998-11-19 |
2001-08-21 |
Smithkline Beecham Corporation |
FabZ
|
WO2000037105A2
(en)
*
|
1998-12-21 |
2000-06-29 |
Medimmune, Inc. |
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
AU2004242430C1
(en)
*
|
1998-12-21 |
2008-06-05 |
Med Immune, Inc. |
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
EA009885B1
(ru)
*
|
1998-12-22 |
2008-04-28 |
Майкросайенс Лимитед |
Применение пептидов бактерий streptococcus группы b, кодирующего их полинуклеотида, вакцина и антитело
|
AP1502A
(en)
|
1998-12-22 |
2005-12-20 |
Microscience Ltd |
Genes and proteins, and their uses.
|
US7128918B1
(en)
*
|
1998-12-23 |
2006-10-31 |
Id Biomedical Corporation |
Streptococcus antigens
|
AU2005209689B2
(en)
*
|
1998-12-23 |
2008-07-17 |
Id Biomedical Corporation Of Quebec |
Novel streptococcus antigens
|
EP1950302B1
(en)
|
1998-12-23 |
2012-12-05 |
ID Biomedical Corporation of Quebec |
Streptococcus antigens
|
DE69938670D1
(de)
*
|
1998-12-23 |
2008-06-19 |
Id Biomedical Corp |
Streptococcus antigene
|
US6340564B1
(en)
*
|
1999-01-26 |
2002-01-22 |
Smithkline Beecham Corporation |
yhxB
|
WO2000044764A1
(en)
*
|
1999-01-28 |
2000-08-03 |
Smithkline Beecham Corporation |
Mvd
|
US6346396B1
(en)
*
|
1999-01-29 |
2002-02-12 |
Jianzhong Huang |
MurA
|
US6306633B1
(en)
|
1999-02-01 |
2001-10-23 |
Smithkline Beecham Corporation |
Polynucleotides encoding mevalonate kinase from Streptococcus pneumoniae
|
WO2000049033A1
(en)
*
|
1999-02-17 |
2000-08-24 |
Smithkline Beecham Corporation |
yybQ
|
US6270762B1
(en)
|
1999-02-26 |
2001-08-07 |
Smithkline Beecham Corporation |
tdk
|
GB9906437D0
(en)
*
|
1999-03-19 |
1999-05-12 |
Smithkline Beecham Biolog |
Vaccine
|
WO2000056884A1
(en)
*
|
1999-03-24 |
2000-09-28 |
Smithkline Beecham Corporation |
pksG
|
US6130069A
(en)
*
|
1999-03-24 |
2000-10-10 |
Smithkline Beecham Corporation |
IspA from Streptococcus pneumoniae
|
WO2000056873A1
(en)
*
|
1999-03-25 |
2000-09-28 |
Smithkline Beecham Corporation |
mvaA
|
CN1198932C
(zh)
*
|
1999-03-26 |
2005-04-27 |
科特克斯(Om)有限公司 |
肺炎链球菌抗原
|
WO2000059514A1
(en)
*
|
1999-04-02 |
2000-10-12 |
Smithkline Beecham Corporation |
Yeaz
|
US7101692B2
(en)
|
1999-04-15 |
2006-09-05 |
The Regents Of The University Of California |
Identification of sortase gene
|
JP2003506011A
(ja)
|
1999-04-15 |
2003-02-18 |
ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア |
ソーターゼ遺伝子の同定
|
US6326167B1
(en)
*
|
1999-04-23 |
2001-12-04 |
Smithkline Beecham Corp. |
TktA from Streptococcus pneumoniae
|
WO2000065026A2
(en)
*
|
1999-04-28 |
2000-11-02 |
Smithkline Beecham Corporation |
YycG
|
US6245542B1
(en)
*
|
1999-05-06 |
2001-06-12 |
Smithkline Beecham Corporation |
tRNA methyltransferase from Streptococcus pneumoniae
|
WO2000070075A1
(en)
*
|
1999-05-17 |
2000-11-23 |
Smithkline Beecham Corporation |
STREPTOCOCCUS PNEUMONIAE yerS
|
NZ545647A
(en)
|
1999-05-19 |
2008-02-29 |
Chiron Srl |
Combination neisserial compositions
|
US6177269B1
(en)
*
|
1999-06-04 |
2001-01-23 |
Smithkline Beecham Corporation, |
aroA
|
ES2360296T3
(es)
*
|
1999-06-10 |
2011-06-02 |
Medimmune, Llc |
Vacunas y proteínas de setreptococcus pneumoniae.
|
US6887480B1
(en)
*
|
1999-06-10 |
2005-05-03 |
Medimmune, Inc. |
Streptococcus pneumoniae proteins and vaccines
|
US6869767B1
(en)
*
|
1999-06-11 |
2005-03-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Detection of Streptococcus pneumoniae and immunization against Streptococcus pneumoniae infection
|
WO2000078785A1
(en)
*
|
1999-06-22 |
2000-12-28 |
Smithkline Beecham Corporation |
lacA
|
US6511839B1
(en)
*
|
1999-06-22 |
2003-01-28 |
Pan Fong Chan |
Fucose kinase
|
WO2000078784A1
(en)
*
|
1999-06-23 |
2000-12-28 |
Smithkline Beecham Corporation |
treP
|
US6291230B1
(en)
*
|
1999-06-23 |
2001-09-18 |
Smithkline Beecham Corporation |
Galk promoter
|
US6884614B1
(en)
|
1999-07-01 |
2005-04-26 |
Basf Aktiengesellschaft |
Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins
|
TR200403465T2
(tr)
*
|
1999-07-01 |
2005-03-21 |
Basf Aktiengesellschaft |
Corynebacterium glutamicum gen kodlayıcı fosfonolpiruvat:seker fosfotransferaz sistem proteini
|
WO2001007463A1
(en)
*
|
1999-07-22 |
2001-02-01 |
Smithkline Beecham Corporation |
Trer
|
WO2001007460A1
(en)
*
|
1999-07-22 |
2001-02-01 |
Smithkline Beecham Corporation |
FucR
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
US6277597B1
(en)
*
|
1999-08-03 |
2001-08-21 |
Smithkline Beecham Corporation |
kdtB
|
EP1075841A1
(en)
*
|
1999-08-13 |
2001-02-14 |
Erasmus Universiteit Rotterdam |
Pneumococcal vaccines
|
US6168797B1
(en)
*
|
1999-08-18 |
2001-01-02 |
Smithkline Beecham Corporation |
FabF
|
WO2001012649A1
(en)
*
|
1999-08-18 |
2001-02-22 |
Smithkline Beecham Corporation |
Aga
|
EP1210366A1
(en)
*
|
1999-08-25 |
2002-06-05 |
Medimmune, Inc. |
Homologs of a pneumococcal protein and fragments for vaccines
|
US6833356B1
(en)
|
1999-08-25 |
2004-12-21 |
Medimmune, Inc. |
Pneumococcal protein homologs and fragments for vaccines
|
WO2001023403A1
(en)
*
|
1999-09-27 |
2001-04-05 |
Smithkline Beecham Corporation |
ypga CLADE GENES
|
WO2001023599A1
(en)
*
|
1999-09-28 |
2001-04-05 |
Smithkline Beecham Corporation |
Streptococcus pneumoniae ykqc
|
CA2906516C
(en)
*
|
1999-09-28 |
2017-03-07 |
Geneohm Sciences Canada Inc. |
Nucleic acids and methods for the detection of streptococcus
|
US6861516B1
(en)
|
1999-10-04 |
2005-03-01 |
Merck & Co., Inc. |
MraY gene and enzyme of pseudomonas aeruginosa
|
US6951729B1
(en)
|
1999-10-27 |
2005-10-04 |
Affinium Pharmaceuticals, Inc. |
High throughput screening method for biological agents affecting fatty acid biosynthesis
|
NZ519669A
(en)
*
|
1999-12-23 |
2004-03-26 |
Vmax Ltd |
Streptococcus pyogenes virulence genes and proteins and their use
|
CA2396040A1
(en)
*
|
1999-12-30 |
2001-07-12 |
Bristol-Myers Squibb Company |
Novel bacterial genes and proteins that are essential for cell viability and their uses
|
CA2335389A1
(en)
*
|
2000-03-01 |
2001-09-01 |
Message Pharmaceuticals, Inc. |
Novel bacterial rnase p proteins and their use in identifying antibacterial compounds
|
FR2807764B1
(fr)
|
2000-04-18 |
2004-09-10 |
Agronomique Inst Nat Rech |
Mutants de bacteries lactiques surproducteurs d'exopolysaccharides
|
AU5577201A
(en)
*
|
2000-04-27 |
2001-11-07 |
Med Immune Inc |
Immunogenic pneumococcal protein and vaccine compositions thereof
|
US6833134B2
(en)
|
2000-06-12 |
2004-12-21 |
University Of Saskacthewan |
Immunization of dairy cattle with GapC protein against Streptococcus infection
|
DK1332155T3
(da)
*
|
2000-06-12 |
2007-02-26 |
Univ Saskatchewan |
Vaccination af malkekvæg med GapC protein mod streptokokinfektion
|
PT1294771E
(pt)
|
2000-06-12 |
2009-01-06 |
Univ Saskatchewan |
Proteína gapc quimérica de streptococcus e sua utilização em vacinação e diagnóstico
|
US6866855B2
(en)
|
2000-06-12 |
2005-03-15 |
University Of Saskatchewan |
Immunization of dairy cattle with GapC protein against Streptococcus infection
|
EP1734050A3
(en)
*
|
2000-06-12 |
2012-12-05 |
University Of Saskatchewan |
Immunization of dairy cattle with GapC protein against streptococcus infection
|
WO2001098334A2
(en)
|
2000-06-20 |
2001-12-27 |
Shire Biochem Inc. |
Streptococcus antigens
|
US7074415B2
(en)
|
2000-06-20 |
2006-07-11 |
Id Biomedical Corporation |
Streptococcus antigens
|
JPWO2002006491A1
(ja)
*
|
2000-07-18 |
2004-01-08 |
株式会社先端科学技術インキュベーションセンター |
イソペンテニル2リン酸イソメラーゼ
|
GB0022742D0
(en)
*
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
US7056697B2
(en)
|
2000-10-06 |
2006-06-06 |
Affinium Pharmaceuticals, Inc. |
FabK variant
|
US7033795B2
(en)
|
2000-10-06 |
2006-04-25 |
Affinium Pharmaceuticals, Inc. |
FabK variant
|
US7048926B2
(en)
|
2000-10-06 |
2006-05-23 |
Affinium Pharmaceuticals, Inc. |
Methods of agonizing and antagonizing FabK
|
US6821746B2
(en)
|
2000-10-06 |
2004-11-23 |
Affinium Pharmaceuticals, Inc. |
Methods of screening for FabK antagonists and agonists
|
CA2426738A1
(en)
*
|
2000-10-26 |
2002-05-02 |
David William Holden |
Streptococcal genes
|
NZ560966A
(en)
|
2000-10-27 |
2010-06-25 |
Novartis Vaccines & Diagnostic |
Nucleic acids and proteins from streptococcus groups A & B
|
MXPA03005386A
(es)
*
|
2000-12-28 |
2004-04-20 |
Wyeth Corp |
Proteina protectora recombinante de streptococcus pneumoniae.
|
EP1227152A1
(en)
*
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
US7262024B2
(en)
|
2001-12-20 |
2007-08-28 |
Id Biomedical Corporation |
Streptococcus antigens
|
US20030211470A1
(en)
*
|
2002-03-15 |
2003-11-13 |
Olson William C. |
CD4-IgG2-based salvage therapy of HIV-1 infection
|
US20030199603A1
(en)
*
|
2002-04-04 |
2003-10-23 |
3M Innovative Properties Company |
Cured compositions transparent to ultraviolet radiation
|
SI2255826T1
(sl)
|
2002-08-02 |
2016-07-29 |
Glaxosmithkline Biologicals S.A. |
Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
|
AU2003268353A1
(en)
*
|
2002-08-30 |
2004-03-19 |
Tufts University |
Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
|
US7615616B2
(en)
*
|
2002-09-13 |
2009-11-10 |
The Texas A&M University System |
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
|
ES2649048T3
(es)
|
2002-11-01 |
2018-01-09 |
Glaxosmithkline Biologicals S.A. |
Procedimiento de secado
|
FR2846668B1
(fr)
*
|
2002-11-05 |
2007-12-21 |
Univ Aix Marseille Ii |
Identification moleculaire des bacteries du genre streptococcus et genres apparentes
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
AU2003286056A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Id Biomedical Corporation |
Streptococcus pneumoniae surface polypeptides
|
GB0302699D0
(en)
*
|
2003-02-06 |
2003-03-12 |
Univ Bradford |
Immunoglobulin
|
AU2004230244B2
(en)
*
|
2003-04-15 |
2011-09-22 |
Intercell Ag |
S. pneumoniae antigens
|
PT1648500E
(pt)
|
2003-07-31 |
2014-10-10 |
Novartis Vaccines & Diagnostic |
Composições imunogénicas para estreptococos piogenes
|
US8945589B2
(en)
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
DE602004028262D1
(de)
|
2003-10-02 |
2010-09-02 |
Glaxosmithkline Biolog Sa |
B. pertussis antigene und ihre verwendung bei der vakzinierung
|
CA2545325C
(en)
|
2003-11-10 |
2015-01-13 |
Uab Research Foundation |
Compositions for reducing bacterial carriage and cns invasion and methods of using same
|
CN1942577A
(zh)
*
|
2003-11-26 |
2007-04-04 |
比纳克斯公司 |
预测传染病状态的方法和试剂盒
|
EP1607485A1
(en)
*
|
2004-06-14 |
2005-12-21 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method for quantifying VEGF121 isoform in a biological sample
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
EP2277595A3
(en)
|
2004-06-24 |
2011-09-28 |
Novartis Vaccines and Diagnostics, Inc. |
Compounds for immunopotentiation
|
US20060165716A1
(en)
|
2004-07-29 |
2006-07-27 |
Telford John L |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
JP2008544949A
(ja)
|
2004-10-08 |
2008-12-11 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
化膿性レンサ球菌のための免疫激性組成物および治療用組成物
|
WO2006048753A2
(en)
*
|
2004-11-05 |
2006-05-11 |
Pharmacia & Upjohn Company Llc |
Anti-bacterial vaccine compositions
|
JP2006223194A
(ja)
*
|
2005-02-17 |
2006-08-31 |
Tosoh Corp |
スタニオカルシン1(STC1)mRNAの測定方法
|
EP2371967B1
(en)
|
2005-03-18 |
2015-06-03 |
DSM IP Assets B.V. |
Production of carotenoids in oleaginous yeast and fungi
|
GB0505996D0
(en)
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
US7476733B2
(en)
*
|
2005-03-25 |
2009-01-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease
|
NZ564606A
(en)
|
2005-06-27 |
2010-10-29 |
Glaxosmithkline Biolog Sa |
Immunogenic composition comprising atleast two N. meningitidis capsular polysaccharides conjugated through a linker protein
|
US20070059716A1
(en)
*
|
2005-09-15 |
2007-03-15 |
Ulysses Balis |
Methods for detecting fetal abnormality
|
EP2357000A1
(en)
|
2005-10-18 |
2011-08-17 |
Novartis Vaccines and Diagnostics, Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
ES2514316T3
(es)
|
2005-11-22 |
2014-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Partículas similares a virus (VLPs) de Norovirus y Sapovirus
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
NO346529B1
(no)
|
2005-12-22 |
2022-09-26 |
Glaxosmithkline Biologicals Sa |
Bruk av et immunogenpreparat for småbarn, omfattende 22F sakkaridkonjugat
|
MY150105A
(en)
|
2006-01-17 |
2013-11-29 |
Forsgren Arne |
A novel surface exposed haemophilus influenzae protein (protein e; pe)
|
EP1998800A2
(en)
|
2006-01-18 |
2008-12-10 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
ATE539079T1
(de)
|
2006-03-23 |
2012-01-15 |
Novartis Ag |
Imidazochinoxalinverbindungen als immunmodulatoren
|
US9182398B2
(en)
|
2006-04-01 |
2015-11-10 |
Medical Service Consultation International, Llc |
Methods and compositions for detecting fungi and mycotoxins
|
EP2589668A1
(en)
|
2006-06-14 |
2013-05-08 |
Verinata Health, Inc |
Rare cell analysis using sample splitting and DNA tags
|
US20080050739A1
(en)
|
2006-06-14 |
2008-02-28 |
Roland Stoughton |
Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
|
MX2009001778A
(es)
*
|
2006-08-17 |
2009-05-22 |
Uab Research Foundation |
Peptidos pcpa inmunogenicos y usos de los mismos.
|
EP2078092A2
(en)
|
2006-09-28 |
2009-07-15 |
Microbia, Inc. |
Production of carotenoids in oleaginous yeast and fungi
|
EP1923069A1
(en)
*
|
2006-11-20 |
2008-05-21 |
Intercell AG |
Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto
|
DK2450054T3
(da)
|
2007-04-12 |
2018-08-13 |
Stichting Katholieke Univ |
Nye virulensfaktorer af Streptococcus pneumoniae
|
CN101688194B
(zh)
*
|
2007-05-23 |
2013-09-11 |
Uab研究基金会 |
去毒的肺炎球菌神经氨酸酶及其用途
|
CN101883583B
(zh)
|
2007-06-26 |
2017-05-17 |
葛兰素史密丝克莱恩生物有限公司 |
含有肺炎链球菌荚膜多糖缀合物的疫苗
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
MX2010002773A
(es)
|
2007-09-12 |
2010-03-31 |
Novartis Ag |
Antigenos mutantes de gas57 y anticuerpos de gas57.
|
EP2537857B1
(en)
|
2007-12-21 |
2017-01-18 |
GlaxoSmithKline Biologicals SA |
Mutant forms of streptolysin O
|
CN102356089B
(zh)
|
2008-02-21 |
2014-02-19 |
诺华股份有限公司 |
脑膜炎球菌fHBP多肽
|
BRPI0909037B8
(pt)
|
2008-03-03 |
2021-05-25 |
Irm Llc |
compostos moduladores da atividade de tlr, e composição farmacêutica
|
WO2009127676A1
(en)
|
2008-04-16 |
2009-10-22 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
US20100068718A1
(en)
|
2008-08-22 |
2010-03-18 |
Hooper Dennis G |
Methods and Compositions for Identifying Yeast
|
EP2174664A1
(en)
|
2008-10-07 |
2010-04-14 |
Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre |
New virulence factors of Streptococcus pneumoniae
|
CN103897045A
(zh)
|
2009-01-12 |
2014-07-02 |
诺华股份有限公司 |
抗革兰氏阳性细菌疫苗中的Cna_B结构域
|
BRPI1006850B8
(pt)
*
|
2009-01-19 |
2021-07-27 |
Biomerieux Sa |
processo para determinar a susceptibilidade para contrair infecção nosocomial
|
HUE049695T2
(hu)
|
2009-03-24 |
2020-10-28 |
Glaxosmithkline Biologicals Sa |
Adjuváló H meningococcus faktort kötõ fehérje
|
WO2010109324A1
(en)
|
2009-03-24 |
2010-09-30 |
Novartis Ag |
Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
EP2440245B1
(en)
|
2009-06-10 |
2017-12-06 |
GlaxoSmithKline Biologicals SA |
Benzonaphthyridine-containing vaccines
|
ES2596653T3
(es)
|
2009-06-16 |
2017-01-11 |
Glaxosmithkline Biologicals Sa |
Ensayos bactericidas de opsonización y dependientes de anticuerpo mediado por el complemento de alto rendimiento
|
WO2011008548A1
(en)
*
|
2009-06-29 |
2011-01-20 |
Genocea Biosciences, Inc. |
Vaccines and compositions against streptococcus pneumoniae
|
US8877356B2
(en)
|
2009-07-22 |
2014-11-04 |
Global Oled Technology Llc |
OLED device with stabilized yellow light-emitting layer
|
SG178954A1
(en)
|
2009-09-02 |
2012-04-27 |
Novartis Ag |
Immunogenic compositions including tlr activity modulators
|
TWI445708B
(zh)
|
2009-09-02 |
2014-07-21 |
Irm Llc |
作為tlr活性調節劑之化合物及組合物
|
CN102695523A
(zh)
|
2009-09-10 |
2012-09-26 |
诺华有限公司 |
针对呼吸道疾病的组合疫苗
|
US8962251B2
(en)
|
2009-10-08 |
2015-02-24 |
Medical Service Consultation International, Llc |
Methods and compositions for identifying sulfur and iron modifying bacteria
|
US9827299B2
(en)
*
|
2009-10-09 |
2017-11-28 |
Children's Medical Center Corporation |
Selectively disrupted whole-cell vaccine
|
WO2011057148A1
(en)
|
2009-11-05 |
2011-05-12 |
Irm Llc |
Compounds and compositions as tlr-7 activity modulators
|
WO2011063264A1
(en)
*
|
2009-11-20 |
2011-05-26 |
University Of Chicago |
Methods and compositions related to immunogenic fibrils
|
MX339146B
(es)
|
2009-12-15 |
2016-05-13 |
Novartis Ag |
Suspension homogenea de compuestos inmunopotenciadores y usos de los mismos.
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
E.coliキャリアタンパク質に結合体化した多糖免疫原
|
CA2814762A1
(en)
*
|
2010-02-11 |
2011-08-18 |
Intelligent Medical Devices, Inc. |
Oligonucleotides relating to clostridium difficile genes encoding toxin b, toxin a, or binary toxin
|
US9290550B2
(en)
|
2010-02-23 |
2016-03-22 |
Stitchting Katholieke Universiteit |
Combination vaccine for Streptococcus
|
US10113206B2
(en)
*
|
2010-02-24 |
2018-10-30 |
Grifols Therapeutics Inc. |
Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
JP2013521770A
(ja)
|
2010-03-10 |
2013-06-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン組成物
|
EA023725B1
(ru)
|
2010-03-23 |
2016-07-29 |
Новартис Аг |
Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
|
WO2011137368A2
(en)
|
2010-04-30 |
2011-11-03 |
Life Technologies Corporation |
Systems and methods for analyzing nucleic acid sequences
|
WO2011149564A1
(en)
|
2010-05-28 |
2011-12-01 |
Tetris Online, Inc. |
Interactive hybrid asynchronous computer game infrastructure
|
US9268903B2
(en)
|
2010-07-06 |
2016-02-23 |
Life Technologies Corporation |
Systems and methods for sequence data alignment quality assessment
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
US9127321B2
(en)
*
|
2010-10-06 |
2015-09-08 |
The Translational Genomics Research Institute |
Method of detecting Coccidioides species
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
MY163871A
(en)
|
2011-01-20 |
2017-10-31 |
Genocea Biosciences Inc |
Vaccines and compositions against streptococcus pneumoniae
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US8877909B2
(en)
|
2011-04-04 |
2014-11-04 |
Intelligent Medical Devices, Inc. |
Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group B Streptococcus
|
BR112013028887B1
(pt)
|
2011-05-11 |
2020-10-06 |
Children's Medical Center Corporation |
Composição imunogênica apresentando múltiplos antígenos, e métodos e usos dos mesmos
|
EA201391456A1
(ru)
|
2011-05-17 |
2014-05-30 |
Глаксосмитклайн Байолоджикалс С.А. |
ВАКЦИНА ПРОТИВ Streptococcus pneumoniae
|
JP2015510872A
(ja)
|
2012-03-07 |
2015-04-13 |
ノバルティス アーゲー |
Streptococcuspneumoniae抗原の増強された製剤
|
CA2876138C
(en)
|
2012-06-14 |
2023-09-19 |
Novartis Ag |
Vaccines for serogroup x meningococcus
|
CN105307684A
(zh)
|
2012-10-02 |
2016-02-03 |
葛兰素史密丝克莱恩生物有限公司 |
非直链糖缀合物
|
WO2014118305A1
(en)
|
2013-02-01 |
2014-08-07 |
Novartis Ag |
Intradermal delivery of immunological compositions comprising toll-like receptor agonists
|
CA2900008A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
WO2015188899A1
(en)
*
|
2014-06-12 |
2015-12-17 |
Deutsches Krebsforschungszentrum |
Novel ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
|
RU2737638C2
(ru)
|
2013-12-03 |
2020-12-01 |
Вирометикс Аг |
ПРОЛИН-БОГАТЫЕ ПЕПТИДЫ, ЗАЩИЩАЮЩИЕ ОТ S.pneumoniae
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
EP3207055A1
(en)
*
|
2014-10-15 |
2017-08-23 |
Xenothera |
Composition with reduced immunogenicity
|
JP6399589B2
(ja)
*
|
2014-10-28 |
2018-10-03 |
国立大学法人山口大学 |
肺炎球菌における発現プロモーター
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
US11866736B2
(en)
*
|
2015-07-31 |
2024-01-09 |
The General Hospital Corporation |
Protein prostheses for mitochondrial diseases or conditions
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
PE20181158A1
(es)
|
2015-12-04 |
2018-07-19 |
Dana Farber Cancer Inst Inc |
Vacunacion con el dominio alfa 3 de mica/b para el tratamiento del cancer
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
WO2018183475A1
(en)
|
2017-03-28 |
2018-10-04 |
Children's Medical Center Corporation |
A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
|
US10525119B2
(en)
*
|
2017-03-31 |
2020-01-07 |
Boston Medical Center Corporation |
Methods and compositions using highly conserved pneumococcal surface proteins
|
KR20200041311A
(ko)
|
2017-06-23 |
2020-04-21 |
노소코미얼 백신 코포레이션 |
면역원성 조성물
|
AR114154A1
(es)
|
2017-12-06 |
2020-07-29 |
Merck Sharp & Dohme |
Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y métodos de uso de estos
|
IL276608B2
(en)
|
2018-02-12 |
2024-04-01 |
Inimmune Corp |
TOLL-like receptor ligands
|
EP3824019A1
(en)
|
2018-07-19 |
2021-05-26 |
GlaxoSmithKline Biologicals SA |
Processes for preparing dried polysaccharides
|
BR112021004193A2
(pt)
|
2018-09-12 |
2021-05-25 |
Affinivax, Inc. |
vacinas pneumocócicas multivalentes
|
CA3123414A1
(en)
|
2018-12-19 |
2020-06-25 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
MX2022006054A
(es)
|
2019-11-22 |
2022-06-24 |
Glaxosmithkline Biologicals Sa |
Dosificacion y administracion de una vacuna de glucoconjugados de sacaridos bacterianos.
|
US11473093B2
(en)
|
2020-11-04 |
2022-10-18 |
Eligo Bioscience |
Cutibacterium acnes recombinant phages, method of production and uses thereof
|
WO2023006825A1
(en)
*
|
2021-07-29 |
2023-02-02 |
Université de Lausanne |
Novel pneumococcal polypeptide antigens
|